8.98
0.00%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zhejiang Xianju Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 002332.SZ. It has been listed since 12 January 2010. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.76bn and net income of CN¥449.6m. At that date it held total assets of CN¥7.26bn and shareholders' equity of CN¥6.04bn.
Zhejiang Xianju Pharmaceutical Co., Ltd. engages in the manufacture and sale of steroid and hormone drugs. The company is headquartered in Taizhou, Zhejiang. The company went IPO on 2010-01-12. is a China-based company principally engaged in the research, manufacture and distribution of steroid active pharmaceutical ingredients (APIs) and preparations. The firm's products are mainly categorized into cortex hormone drugs, gynecology and family planning drugs, as well as anesthesia drugs and muscle relaxants. The firm is also involved in the provision of respiratory drugs, immunomodulators, dermatology drugs, anaesthetic drugs and others. The firm distributes its products in domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 12 Jan 2010
- Employees
- 3,336
- Website
- xjpharma.com ↗
Leadership
Pay as last reported
- Mr. Yusong ZhangChairman of the Board, General Manager, since 2007CN¥1.5m
- Ms. Yaohua WangChief Financial OfficerCN¥968,100
- Mr. Wangwei ZhangDeputy General Manager, Secretary of the Board, Director, since 2024CN¥516,000
- Mr. Zhun XuDeputy General Manager, DirectorCN¥1.0m
- Mr. Carlo CartasegnaDeputy General ManagerCN¥924,600
- Mr. Weihua JinDeputy General ManagerCN¥1.1m
- Mr. Minghua YingDeputy General ManagerCN¥993,000
- Mr. Baohu CaoDirector
- Mr. Weiwu ChenDirector
- Mr. Ruwei LuDirector
- Mr. Guojun ZhangDirector
- Mr. Kanghua ChenIndependent DirectorCN¥72,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zhejiang Xianju Pharmaceutical employs 3336 full-time employees in Taizhou, China.
- The company manufactures steroid and hormone drugs for domestic and overseas markets.
- Zhejiang Xianju focuses on cortex hormone drugs and gynecology products in its portfolio.
Weaknesses
- The company's business is limited to steroid and hormone drugs with no diversification.
- Zhejiang Xianju has no presence in the Information Technology sector or other industries.
- The firm's product range lacks respiratory and immunomodulator drugs in its core offerings.
Opportunities
- Expanding into the global pharmaceutical market for steroid APIs could increase revenue.
- Growing demand for gynecology and family planning drugs presents a market opportunity.
- The company can leverage its focus on anesthesia drugs to enter new markets.
Threats
- Competition from other Chinese pharmaceutical companies in steroid APIs is increasing.
- Regulatory changes in the Health Care sector may affect production.
- Overreliance on the domestic market could limit growth potential.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.